PMSA 2024 Annual Conference

The Countdown Begins: Preparing for the PMSA 2024 Conference

With the arrival of spring, the excitement for the Pharmaceutical Management Science Association’s 48th Annual Conference, set to kick off during the first week of May 2024, starts to build. This year, the bustling city of Denver, Colorado gets to play host to this prestigious event, a much-anticipated gathering for pharmaceutical data professionals across the world. The PMSA Conference consistently provides an exceptional platform for these professionals to converge, exchange knowledge, innovate, and inspire each other.

This year, we are proud to announce that our team from Claritas Rx will be attending the event as sponsors. The conference is scheduled to be held at Hyatt Regency in Denver from May 5–8.

As we begin our preparations, several sessions have piqued our interest, including: 

  1. “Using Large Foundational Models to Mine Insights for Prostate Cancer Treatment” – General Session 1
    This session, led by esteemed speakers Prakash Karaka, Suzanne Marzziotti from Chryselys, and Gary Fu from Novartis, promises to provide a detailed discussion on an integral medical issue.
  2. “Filling the Gap between Market Segmentation and Marketing Strategy: the Synergy of Market Segmentation and Causal Inference” – General Session 3
    Presented by Kaihua Ding from AstraZeneca, this session will delve into the dynamic domain of marketing strategy. Traditional segmentation, while helpful in profiling consumers and Healthcare Professionals (HCPs), often fails to shed light on the underlying decision-making factors. This session proposes an innovative bridge between conventional market segmentation and the dynamic analysis of consumer behavior. The iterative causal segmentation method introduced here has the potential to dramatically transform marketing efforts, enabling these to be tailored to each customer segment with powerful resonance.
  3. “Data Strategy for RLT” – Track 6B
    Experts Gunjan Aggarwal and Brian Garino from Novartis will explore the rapidly evolving approach to data strategy, especially about Real-World Late-phase Research (RLT), stressing the necessity for strategies adapted to the complexity of various brand dimensions within RLT. Their discussion promises a comprehensive understanding of brand dimensions, macro trends, RLT data challenges, data gap solutions, and data solution development.

Finally, we are thrilled to announce that we are contributing to the academic reservoir of the conference through our article, which has been officially forwarded for publication in the prestigious Journal of the Pharmaceutical Management Science Association (PMSA Journal). With great anticipation, we look forward to the digital unveiling of this scholarly article at the upcoming spring conference. In addition, our latest white paper will be in the spotlight through a PMSA Poster Abstract display.

Are you looking to gain valuable insights from specialty pharmacies, hubs, and other market data? Visit booth #102 to learn how Claritas Rx can help your organization unlock critical information and stay ahead of the competition. Our competitive insights solution goes beyond just claims data, giving you the power to respond quickly and effectively to industry events. Don’t miss out on this opportunity to revolutionize your approach to data analysis! Schedule a meeting with our experts, David Bradford or David Frank, today.

As we anticipate the 2024 PMSA conference with excitement, we look forward to the wealth of knowledge and insights it promises to offer, and we can’t wait to participate in the enlightening discussions ahead. We hope to see you there!